1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo...

34
1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA

Transcript of 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo...

Page 1: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

1

Glycemic control and highly infected diabetic foot

Dr. Sanjeev Kelkar M.D.

Medical Director

Novo Nordisk Education Foundation,

Bangalore, INDIA

Page 2: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

2

Glycemic control and infected diabetic foot

- The infective catabolic insulin resistant state

- Aggressive approach

- Methods of control

- Limitations

- Nutritional considerations

- General management

Page 3: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

3

Glycemic control anddiabetic foot

The infected foot: 1

Infected large ulcers

Apparent / unapparent deep seated abscesses

Wide-spread infection and subsequent inflammation

Page 4: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

4

Glycemic control anddiabetic foot

The infected foot:2

Failure of body to localize the infection*

Endotoxemia

Septicaemia

Necrotising fascitis

Multiorgan failure

Page 5: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

5

Glycemic control anddiabetic foot

The infected foot: 3

Febrile, toxic, catabolic state,

Tissue breakdown high,

Negative nitrogen balance,

High degree of insulin resistance

Nutritional support difficult

Critical care setting

Page 6: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

6

Glycemic control anddiabetic foot

The infected foot: 4

On the horns of dilemma:

Glycemic control haywire, difficult to achieve

Cause of uncontrolled diabetes is

in foot infection

Foot cannot be tackled as control is poor

Balance – golden mean necessary

Page 7: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

7

Glycemic control anddiabetic foot

The aggressive approach: 1

Medical assessment

Hydration / Nutrition

Antibiotics

Surgical treatment - Operative /

Conservative

Insulin administration

Page 8: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

8

Glycemic control anddiabetic foot

The aggressive approach - 2

Establishing investigative parameters:

Hemogram – baseline counts, peripheral smear picture, status of anemia

Urine – ketones – as a baseline and guide of management

Albumin for nephropathy

Page 9: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

9

Glycemic control anddiabetic foot

The aggressive approach – 3

Renal parameters: baseline creatinine

Patient likely to go in ARF

For monitoring recovery if so

Electrolytes: Sodium for functional importance, K+ a dangerous cation in ARF

Page 10: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

10

Glycemic control anddiabetic foot

The aggressive approach – 4 Renal parameters – daily onceElectrolytes – even multiple monitoring in a day may be essential.Blood gases: To distinguish metabolic / respiratory acidosis – mixed pictures -Important monitoring aid for acid /base status* To assess hypoxic status

Page 11: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

11

Glycemic control anddiabetic foot

The aggressive approach– 5

Baseline electrocardiogram for normal variant patterns – LBBB, IRBB, RBBB, bigeminy

Baseline chest x-ray:

For comparing newer shadows – ARDS, PTE, collapse, consolidation, effusion,

Pneumothrorax

Page 12: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

12

Glycemic control anddiabetic foot

The aggressive approach – 6

Glucose monitoring:

Multiple blood glucose monitoring

Timing and type of insulin therapy coinciding with monitoring

Bedside rapid assay - reliable meters

proper technique and daily calibration - mandatory

Page 13: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

13

Glycemic control anddiabetic foot

The aggressive approach – 7

Assessing hydration: 1

Central venous access - brachial

Reliable, often mandatory

Facilitates rapid hydration

Multiple IV access possible,

Dehydration – invitation to ARF, thrombosis

Page 14: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

14

Glycemic control anddiabetic foot

The aggressive approach – 8

Types of central venous access -

The best: Sub-clavian - costly, needs expertise

Very occasionally pneumothorax

Advantages:

Most reliable for assessing hydration status

Can be maintained for longContd.

Page 15: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

15

Glycemic control anddiabetic foot

The aggressive approach – 8

Multiple infusions through 3 ways possible

TPN – easy. Low infectivity.

Ambulation possible

Frees legs and arms

Jugular messy, inconvenient, difficult to maintain, administer drugs, specially on respirators

Page 16: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

16

Glycemic control anddiabetic foot

The aggressive approach – 9

Next best: Anticubital

Easy, less costly

Reliable for hydration assessment

Low infective potential

TPN not difficultContd.

Page 17: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

17

Glycemic control anddiabetic foot

The aggressive approach – 9

Anticubital maintained 7 –10 days

Femoral – avoided far as possible

Central venous pressure monitoring –

A must, 1/2/3/day

Page 18: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

18

Glycemic control anddiabetic foot

The aggressive approach – 10

Nutrition: Higher calorie intake mandatory

Higher insulin dosing mandatory

TPN: If intake is poor, if serum albumin low

Begin as early as felt required

200 gm of glucose mandatory per day

Lipids / albumin infusion / whole blood

Ready tube feeding mixtures, costly but have balanced elements, vitamins.

Page 19: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

19

Glycemic control anddiabetic foot

The aggressive approach – 11

Antibiotics:

Infections often mixed

Cephalosporins

Quinolones

Aminoglycosides – Amikacin, Metronidazole

Guided by: Blood Culture, wound swabs

Page 20: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

20

Glycemic control anddiabetic foot

The aggressive approach – 12

Blood culture:

10 – 15 ml blood to be drawn

Before antibiotics or

Just prior to next dose

Pus culture from wounds

Page 21: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

21

Glycemic control anddiabetic foot

Insulin regimens: 1

In the worst cases:

Food intake poor,

Dependence on iv insulin therapy

No glucose infusions if blood glucose

> 400 mg,

Normal saline preferred

Page 22: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

22

Glycemic control anddiabetic foot

Insulin regimens: 2

DKA - .4 units x kg body weight

Rapid acting insulin – bolus ½ IV,

½ IM (if no hypotension)

N / ½ N Saline with 5 – 7 u/hr

The rate or the insulin concentration

can be varied

Page 23: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

23

Glycemic control anddiabetic foot

Insulin regimens: 3

Hourly monitoring if BG > 400 mg/dl

Infuse dextrose with insulin – once glucose is lowered to about 200 mg/dl

Start dextrose saline 5 – 7 u/hr

Monitor, adjust

K+ supplements – freely if kidneys are intact, urine output is good, hydration established

Page 24: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

24

Glycemic control anddiabetic foot

Insulin regimens: 4 - Thumb rules:

Blood glucose < 100 mg/dl No insulin

100 – 200 mg/dl 1 – 2 u/hr

200 – 300 mg/dl 2 – 3 u/hr

300 – 400 mg/dl 3 – 4 u/hr

>400 mg N Saline + 5 – 7 u/hr (100 ml/hr)

Scales need upward shifting 1.5 to 3 – 4 times

Page 25: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

25

Glycemic control anddiabetic foot

Insulin regimens: 5 K+ supplementation: Calculations:

Needs – in DKA at baseline 250 mmol / d .3 (4 - K+ in serum) x kg body weight Readjustments depending on monitoring Na replacements: .6 x (140 – Na+) x body weight, Bicarbs better avoided

Page 26: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

26

Glycemic control anddiabetic foot

Results:

Hydration, CVP 10-12 cms

Respiratory rate , Pulse rate

Blood pressure stabilizes

Blood gas – pH 7.3, HCO3 15 mmol/L

Blood glucose 150-200 mg/dl ketones may persist

Patient ready for surgery

Page 27: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

27

Glycemic control anddiabetic foot

In less severe cases:

Patient not acidotic

Is able to eat, drink

Infection spread arrested

Needs surgical intervention

I.V. dependence not heavy

Other insulin regimens

Page 28: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

28

Glycemic control anddiabetic foot

In hospital insulin regimens:

MSII –

Rapid acting insulin before breakfast, before lunch and around 5 p.m.

Before dinner –

Rapid + intermediate acting insulin, sc

Page 29: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

29

Glycemic control anddiabetic foot

Monitoring MSII

Fasting blood glucose

Pre lunch (decides fasting as well as pre

lunch dose)

Post lunch – can modulate 5 p.m. dose

Pre dinner –

Rapid control possible

Page 30: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

30

Glycemic control anddiabetic foot

MSII Cascading doses:

Relatively higher pre breakfast

Insulin – 12 – 16 or more units

Pre lunch 2 – 4 units less

5 p.m. – further 2 – 4 units less

Pre dinner – adjusted

Intermediate acting controls Dawn phenomenon

Page 31: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

31

Glycemic control and diabetic footPost operatively or in a more stable patient

Split mix – 30:70 or 50:50

Recent trial – equal rating

Pre – dinner and pre breakfast

Could be supplemented by a short acting

pre lunch small dose 6 – 10 units

Monitoring – fasting, post lunch

Post dinner or pre dinner

Page 32: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

32

Glycemic control anddiabetic foot

Distinctions - 1

Hydrating fluids (mainly saline) separate from insulin infusions.

Rate of infusion may vary.

Blood adds to glucose levels marginally.

I.V. fructose may lead to hypertriglyceridema

Lipids – insulin required for metabolism

Page 33: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

33

Glycemic control anddiabetic foot

Distinctions - 2

Protein intake – renal status must be the guide

Sodium – important for neurological function / SIADH

Potassium – severe hypokalemia – dangerous arrhythemia

Hyperkalemia – indication for correction - dialysis

Page 34: 1 Glycemic control and highly infected diabetic foot Dr. Sanjeev Kelkar M.D. Medical Director Novo Nordisk Education Foundation, Bangalore, INDIA.

34

Glycemic control anddiabetic foot

Distinctions - 3

Hyperkalemia – cardiac standstill

Remove all possible potassium administration

100 mg hydrocortisone – SOS repeat

I.V. frusemide 40 – 80 mg/dl

Na bicarbonate I.V.

Dialyse